Tirzepatide, the dual GLP-1 and GIP receptor agonist marketed as Mounjaro, works by signaling your brain to reduce hunger while slowing stomach emptying
This dual action can influence appetite, energy metabolism, and blood sugar regulation in potentially different ways than a GLP-1-only drug, which may translate to greater average weight loss for some patients
They are typically caused by the way the medication slows down digestion, which can lead to increased stomach pressure or acid reflux that triggers the diaphragm
It is often discussed in experimental research around tissue response, connective tissue, tendon and ligament models, angiogenesis-related studies and gastrointestinal research models
Here's an overview of the weight loss medications you can access at our clinics near you: Wegovy (Semaglutide Injection) Wegovy is a semaglutide injection designed specifically for weight loss